Viewing nowDio Saltan Tablet 80 mg (Valsartan)
Valsartan 80mg
Tablet · Prescription medication
Yuhan Corporation

MFDS item code 200811105 · Notified 2008.11.20 · Insurance code 642104030
Treatment of essential hypertension and heart failure; reduces the risk of death after myocardial infarction
This medication is used to effectively control blood pressure in patients with essential hypertension. It is also suitable for heart failure patients who show intolerance to ACE inhibitors, particularly those classified as NYHA class II to IV. Additionally, it helps reduce the risk of mortality after myocardial infarction in stable patients with left ventricular failure or dysfunction. Through these effects, it improves cardiovascular health and supports the overall quality of life of patients. Thus, this drug is widely used for hypertension, heart failure, and post-myocardial infarction treatment.
1. Essential hypertension Take with water during a meal or between meals. If possible, it is recommended that the medicine be taken at the same time each day (e.g., in the morning). 1) Adults: Regardless of sex or race, the recommended dose is 80 mg of valsartan orally once daily. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg daily or a diuretic may be coadministered. If further blood pressure reduction is needed, the dose may be increased to a maximum of 320 mg daily. 2) Older adults (75 years and older): Start treatment with 40 mg of this medicine once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Start treatment with 40 mg of this medicine once daily. (3) Creatinine clearance less than 10 mL/min and patients on dialysis: Do not administer this medicine. 4) Patients with volume depletion: In patients with volume depletion (e.g., patients taking high doses of diuretics whose dose cannot be reduced), start treatment with 40 mg of this medicine once daily. 5) Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, start treatment with 40 mg of this medicine once daily; the dose should not exceed 80 mg daily. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg of this medicine orally twice daily; the dose may be increased to 80 mg or 160 mg per dose. When coadministering a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, administered in divided doses. Triple combination therapy with this medicine, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Adults: Treatment may be started within 12 hours after the onset of myocardial infarction. The recommended starting dose is 20 mg of this medicine twice daily, followed by dose increases over several weeks, as tolerated by the patient, to 40 mg, 80 mg, and 160 mg per dose twice daily. Consider dose reduction if symptoms of hypotension or renal failure occur. This medicine may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 10 mL/min or higher; however, do not administer this medicine to patients with a creatinine clearance less than 10 mL/min or to patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: For patients with mild or moderate hepatic impairment, the daily dose of this medicine should preferably not exceed 80 mg. If administering 80 mg or more daily, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis.
6) Children: Safety and efficacy have not been established in children and adolescents under 18 years of age. 6. Children: Safety and efficacy have not been established in children and adolescents under 18 years of age.
This drug can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used by patients with allergies to this drug, severe liver or kidney dysfunction, or women who are pregnant or breastfeeding. Caution is needed when this drug is used in elderly patients, those with high potassium levels, patients with mild liver dysfunction, and those with valvular or cardiovascular diseases. During the initial administration, blood pressure may fall suddenly, causing dizziness or fainting, so particularly in patients taking diuretics or with low sodium levels, treatment should start with a low dose and conditions should be closely monitored. While taking this drug, side effects such as headache, dizziness, fatigue, cough, diarrhea, etc., may occur, and more rarely, serious side effects such as angioedema, hepatitis, or renal dysfunction may also occur, so any unusual symptoms should be reported to healthcare professionals immediately. Interactions may occur when this drug is taken with other blood pressure medications, diuretics, or anticoagulants, so it is essential to inform the healthcare provider of any other medications being taken. Women who are pregnant or planning to become pregnant should not use this drug, and its use should be avoided during breastfeeding. The safety and effectiveness of this drug in children and adolescents have not been sufficiently established, so it is advisable not to use it in this age group. In case of overdose, severe hypotension, reduced consciousness, or shock may occur, necessitating immediate emergency treatment, as blood dialysis is not effective. This drug should be kept out of reach of children, and transferring it to other containers may lead to decreased quality or accidents, so be cautious.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent exposure to air and humidity, and it is recommended to store it in a cool place below 30 degrees Celsius. This helps maintain the drug's effectiveness for a longer period.
Pale red round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowValsartan 80mg
Tablet · Prescription medication
Yuhan Corporation

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.